Akebia Therapeutics dba Keryx Biopharmaceutials, Inc: Drug Recall
Recall #D-0260-2021 · 01/29/2021
Class III: Low Risk
Recall Details
- Recall Number
- D-0260-2021
- Classification
- Class III
- Product Type
- Drug
- Recalling Firm
- Akebia Therapeutics dba Keryx Biopharmaceutials, Inc
- Status
- Terminated
- Date Initiated
- 01/29/2021
- Location
- Cambridge, MA, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 17,664 bottles
Reason for Recall
Failed Dissolution Specifications
Product Description
Auryxia (ferric citrate) tablets, 210 mg*, 200 tablets bottle, RX ONLY, Manufactured for and distributed by: KERYX BIOPHARMACEUTICALS, INC., 245 First Street, Suite 1400, Cambridge, MA 02142, USA, NDC 59922-0631-01.
Distribution Pattern
Nationwide.
Other Recalls by Akebia Therapeutics dba Keryx Biopharmaceutials, Inc
- Class II: Risk 12/09/2020
View all recalls by Akebia Therapeutics dba Keryx Biopharmaceutials, Inc →
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.